by Jasmine | Dec 23, 2020 | News
Vancouver, British Columbia–(Newsfile Corp. – December 23, 2020) – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FSE: 2VPA) (“Veritas” or the “Company”) is pleased to announce that it expects to complete the Due Diligence...
by Jasmine | Sep 9, 2020 | News
Vancouver, British Columbia–(Newsfile Corp. – September 9, 2020) – Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VPA) (“Veritas” or the “Company“) is pleased to announce that it has entered into a business...
by Jasmine | Jul 28, 2020 | News
Vancouver, British Columbia–(Newsfile Corp. – July 28, 2020) – Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP) (“Veritas” or the “Company“) wishes to announces that it has entered into debt settlement agreements...
by Jasmine | May 22, 2020 | News
VANCOUVER, British Columbia, May 22, 2020 – Veritas Pharma Inc.’s (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that on May 14th, 2020, the company entered into a Letter of Intent (“LOI”) to acquire Indigenous...
by Jasmine | May 21, 2020 | News
VANCOUVER, British Columbia, May 21st, 2020 – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) wishes to announce that as a result of a review of its continuous disclosures record by the British Columbia Securities...
by Jasmine | Apr 27, 2020 | News
VANCOUVER, British Columbia, April 27th, 2020 – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) wishes to announce that it has issued 1,215,789 options to directors and officers of the Company under the stock option...
